Aggreguide A-100 ADP Assay Evaluation

Completed

• Conditions: ADP Blockers; Platelet Aggregation
• Interventions: Other: platelet aggregation measurement

• Registration Number: NCT02112539
• Lead Sponsor: Aggredyne, Inc.

Brief Summary

The study is to characterize the AggreGuide ADP Assay's performance.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-03
• Study First Submitted: 2014-04-10
• Study First Submitted QC: 2014-04-10
• Study First Posted: 2014-04-14
• Primary Completion: 2014-08
• Study Completion: 2014-08
• Status Verified: 2017-04
• Last Update Submitted: 2017-04-02
• Last Update Posted: 2017-04-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• 18-75

Exclusion Criteria

• less than 60 kg
• on antiplatelet meds other than aspirin
• antiplatelet drugs contraindicated

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
ADP Blockers	platelet aggregation measurement	platelet aggregation in response to antiplatelet drugs

Primary Outcome Measures

Name	Time	Method
Platelet Activity Index (PAI)	1 week	PAI at baseline and after taking ADP blocking antiplatelet drugs.

Trial Locations

Locations (1)

Juno Research; 🇺🇸 Houston, Texas, United States